About Jeffrey Tong
Form D filings for Asher Biotherapeutics from 2021 to 2024 list Jeffrey Tong as director.
Jeffrey Tong first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Tong in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Tong works with at each company, as listed on that company's latest Form D.
Asher Biotherapeutics, Inc. · Form D, Apr 16, 2024
CG
Craig Gibbs
Chief Executive Officer and director
ID
Ivana Djuretic
Executive officer and director
Reid Huber
Director
KE
Kyle Elrod
Executive officer
BD
Bob Deresiewicz
Director
ES
Elaine Sun
Director
AY
Andy Yeung
Executive officer
DS
Don O'Sullivan
Executive officer
IC
Ian Clark
Director